Validation of the functional assessment of cancer therapy esophageal cancer subscale

Gail Darling, David T Eton, Joanne Sulman, Alan G. Casson, David Cella

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

BACKGROUND. To develop and validate a quality of life subscale for patients with esophageal cancer to be used with the Functional Assessment of Cancer Therapy-General (FACT-G). METHODS. Prospective cohort study of patients with esophageal cancer treated with surgery alone or neoadjuvant chemoradiotherapy and surgery evaluating the validity, internal consistency, and responsiveness to change of the FACT-Esophageal (FACT-E) when comparing it with the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ 30) and esophageal (OES 24) as well as clinical factors. RESULTS. The FACT-E demonstrated very good convergent and divergent validity when compared with the EORTC QLQ30 and OES 24 and clinical variables. Internal consistency was also good with coefficient α >0.70 for all subscales and individual items. Stability coefficients were >0.80. Changes in clinical status were reflected in changes in FACT-E scores demonstrating responsiveness to change, particularly in patients receiving neoadjuvant chemoradiotherapy before surgery. CONCLUSIONS. The FACT-E met or exceeded all standards for validity, providing an option to measure health-related quality of life for different treatment strategies for esophageal cancer.

Original languageEnglish (US)
Pages (from-to)854-863
Number of pages10
JournalCancer
Volume107
Issue number4
DOIs
StatePublished - Aug 15 2006
Externally publishedYes

Fingerprint

Esophageal Neoplasms
Quality of Life
Chemoradiotherapy
Neoplasms
Cohort Studies
Therapeutics
Organizations
Prospective Studies
Research

Keywords

  • Cancer treatment
  • Esophageal neoplasm
  • health-related quality of life
  • Quality of life

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Validation of the functional assessment of cancer therapy esophageal cancer subscale. / Darling, Gail; Eton, David T; Sulman, Joanne; Casson, Alan G.; Cella, David.

In: Cancer, Vol. 107, No. 4, 15.08.2006, p. 854-863.

Research output: Contribution to journalArticle

Darling, Gail ; Eton, David T ; Sulman, Joanne ; Casson, Alan G. ; Cella, David. / Validation of the functional assessment of cancer therapy esophageal cancer subscale. In: Cancer. 2006 ; Vol. 107, No. 4. pp. 854-863.
@article{2513c2fb5a314a31b95333dc9d125003,
title = "Validation of the functional assessment of cancer therapy esophageal cancer subscale",
abstract = "BACKGROUND. To develop and validate a quality of life subscale for patients with esophageal cancer to be used with the Functional Assessment of Cancer Therapy-General (FACT-G). METHODS. Prospective cohort study of patients with esophageal cancer treated with surgery alone or neoadjuvant chemoradiotherapy and surgery evaluating the validity, internal consistency, and responsiveness to change of the FACT-Esophageal (FACT-E) when comparing it with the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ 30) and esophageal (OES 24) as well as clinical factors. RESULTS. The FACT-E demonstrated very good convergent and divergent validity when compared with the EORTC QLQ30 and OES 24 and clinical variables. Internal consistency was also good with coefficient α >0.70 for all subscales and individual items. Stability coefficients were >0.80. Changes in clinical status were reflected in changes in FACT-E scores demonstrating responsiveness to change, particularly in patients receiving neoadjuvant chemoradiotherapy before surgery. CONCLUSIONS. The FACT-E met or exceeded all standards for validity, providing an option to measure health-related quality of life for different treatment strategies for esophageal cancer.",
keywords = "Cancer treatment, Esophageal neoplasm, health-related quality of life, Quality of life",
author = "Gail Darling and Eton, {David T} and Joanne Sulman and Casson, {Alan G.} and David Cella",
year = "2006",
month = "8",
day = "15",
doi = "10.1002/cncr.22055",
language = "English (US)",
volume = "107",
pages = "854--863",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Validation of the functional assessment of cancer therapy esophageal cancer subscale

AU - Darling, Gail

AU - Eton, David T

AU - Sulman, Joanne

AU - Casson, Alan G.

AU - Cella, David

PY - 2006/8/15

Y1 - 2006/8/15

N2 - BACKGROUND. To develop and validate a quality of life subscale for patients with esophageal cancer to be used with the Functional Assessment of Cancer Therapy-General (FACT-G). METHODS. Prospective cohort study of patients with esophageal cancer treated with surgery alone or neoadjuvant chemoradiotherapy and surgery evaluating the validity, internal consistency, and responsiveness to change of the FACT-Esophageal (FACT-E) when comparing it with the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ 30) and esophageal (OES 24) as well as clinical factors. RESULTS. The FACT-E demonstrated very good convergent and divergent validity when compared with the EORTC QLQ30 and OES 24 and clinical variables. Internal consistency was also good with coefficient α >0.70 for all subscales and individual items. Stability coefficients were >0.80. Changes in clinical status were reflected in changes in FACT-E scores demonstrating responsiveness to change, particularly in patients receiving neoadjuvant chemoradiotherapy before surgery. CONCLUSIONS. The FACT-E met or exceeded all standards for validity, providing an option to measure health-related quality of life for different treatment strategies for esophageal cancer.

AB - BACKGROUND. To develop and validate a quality of life subscale for patients with esophageal cancer to be used with the Functional Assessment of Cancer Therapy-General (FACT-G). METHODS. Prospective cohort study of patients with esophageal cancer treated with surgery alone or neoadjuvant chemoradiotherapy and surgery evaluating the validity, internal consistency, and responsiveness to change of the FACT-Esophageal (FACT-E) when comparing it with the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ 30) and esophageal (OES 24) as well as clinical factors. RESULTS. The FACT-E demonstrated very good convergent and divergent validity when compared with the EORTC QLQ30 and OES 24 and clinical variables. Internal consistency was also good with coefficient α >0.70 for all subscales and individual items. Stability coefficients were >0.80. Changes in clinical status were reflected in changes in FACT-E scores demonstrating responsiveness to change, particularly in patients receiving neoadjuvant chemoradiotherapy before surgery. CONCLUSIONS. The FACT-E met or exceeded all standards for validity, providing an option to measure health-related quality of life for different treatment strategies for esophageal cancer.

KW - Cancer treatment

KW - Esophageal neoplasm

KW - health-related quality of life

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=33747188339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747188339&partnerID=8YFLogxK

U2 - 10.1002/cncr.22055

DO - 10.1002/cncr.22055

M3 - Article

C2 - 16826587

AN - SCOPUS:33747188339

VL - 107

SP - 854

EP - 863

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -